Jim Simons Scopus Bio Pharma Inc. Transaction History

Renaissance Technologies LLC

  • $56.7 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.23 - $0.45 $16,042 - $31,386
-69,748 Reduced 53.3%
61,104 $15,000
Q2 2022

Aug 12, 2022
BUY
$0.36 - $0.74 $6,598 - $13,563
18,329 Added 16.29%
130,852 $56,000
Q1 2022

May 13, 2022
BUY
$0.6 - $1.7 $54,973 - $155,759
91,623 Added 438.39%
112,523 $78,000
Q4 2021

Feb 11, 2022
BUY
$1.63 - $4.28 $34,067 - $89,452
20,900 New
20,900 $34,000

Others Institutions Holding SCPS

# of Institutions
1
Shares Held
100
Call Options Held
0
Put Options Held
0
View Full List

About Scopus BioPharma Inc.

SCPS Quotes by TradingView
  • Ticker SCPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,094,300
  • Description
  • Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...
More about SCPS
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email